
|Articles|June 1, 2012
- Pharmaceutical Executive-06-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - June 2012
2012 Dealmakers Roundtable
Advertisement
Articles in this issue
about 14 years ago
Gamification Grows Upabout 14 years ago
Raising the Stakes in CNSabout 14 years ago
A Brand Positioning Nightmareabout 14 years ago
Europe Responds to Medical Device 'Crisis'about 14 years ago
Marketing: Medical Devices vs. Pharmaabout 14 years ago
Innovation and Collaborationabout 14 years ago
From the Editor:The Connections GameAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
2
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
3
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering
4
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
5




